HOME
LOGIN
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Reference Tables
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
DRUG INTERACTIONS
PRODUCTS
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1590
January 27, 2020
Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder that has been diagnosed in up to 10% of school-age children in the US and frequently persists into adulthood. A study in a large Danish cohort found that ADHD was associated with higher mortality rates in children, adolescents, and adults, mainly due to accidents. Pharmacologic treatment of ADHD in children has been reported to decrease the risk of substance abuse in adolescents, and use of ADHD medications in adults has been associated with a reduced risk of serious...  read more...
More from issue 1590
Coming Soon
Istradefylline (Nourianz) for Parkinson's Disease
Reduction of Cardiovascular Risk with Icosapent Ethyl (Vascepa)
Drospirenone (Slynd) - A New Progestin-Only Oral Contraceptive
Brolucizumab (Beovu) for Age-Related Macular Degeneration
Drugs for Depression
Recommend to Your Library  
Previous Issues
© 2020 The Medical Letter, Inc.